China Resources Boya Bio-pharmaceutical Issues Sharp 2025 Profit Warning
China Resources Boya Bio-pharmaceutical, a key player in biopharma, has flagged a steep profit drop for 2025, projecting net profit attributable to shareholders at RMB105 million to RMB136.5